查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1541226

2024-2032 年按类型、应用（心室内不同步、心室间不同步、房室不同步）、最终用户和地区分類的心臟再同步治疗市场报告

Cardiac Resynchronization Therapy Market Report by Type, Application (Intraventricular Dyssynchrony, Interventricular Dyssynchrony, Atrioventricular Dyssynchrony), End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3个工作天内

价格

2023年，全球心臟再同步治疗（CRT）IMARC Group规模达57亿美元。心臟衰竭盛行率的上升、政府和监管支持的增加、有利的报销政策以及新兴经济体医疗基础设施的扩张是推动市场的一些主要因素。

心臟再同步治疗（CRT）是一种先进的医疗程序，用于治疗某些患者的心臟衰竭症状。这种治疗涉及使用一种透过手术植入胸部的专用设备，称为 CRT 设备，类似于起搏器。该装置的工作原理是将电脉衝传输到心室，从而协调它们的收缩。这种同步可以提高心臟的效率，减轻经常伴随心臟衰竭的疲劳和呼吸急促等症状。对于患有中度至重度心臟衰竭且心臟内电紊乱证据的个体，通常会考虑 CRT 并结合最佳的药物治疗。 CRT 的实施标誌着一种有针对性的心臟衰竭治疗方法，旨在提高患者的生活品质和整体功能能力。

医疗保健基础设施的快速发展，特别是在新兴经济体，在扩大 CRT 设备的覆盖范围方面发挥着至关重要的作用，这将刺激预测期内的市场成长。随着各国投资现代化医疗设施、培训医疗保健专业人员和加强医疗保健系统，获得 CRT 等专业治疗的机会变得越来越普遍。再加上医疗旅游业的兴起，患者在以具有竞争力的成本提供先进医疗技术的国家寻求治疗，正在推动市场成长。此外，不断增加的公私伙伴关係正在促进政府和私人实体之间的合作，以资助和促进 CRT。透过教育活动和专业研讨会提高患者意识也促进了 CRT 的理解和接受，加快了产品的采用率。此外，製造商之间在产品开发、行销和分销方面的策略合作正在支持市场成长。除此之外，提供具有成本效益的 CRT 解决方案的本地製造商的出现正在促进竞争并使治疗更容易获得，从而推动心臟再同步治疗市场的成长。

心臟再同步治疗 (CRT) 市场趋势/驱动因素：

心臟衰竭盛行率增加

全球心臟衰竭发生率的上升是推动心臟再同步治疗（CRT）市场成长的关键因素。随着心臟衰竭变得越来越普遍，特别是在人口老化以及肥胖和糖尿病发病率增加的地区，对 CRT 等有效治疗方法的需求正在增加。 CRT 能够改善特定心臟衰竭患者的症状和整体生活质量，这凸显了其重要性。各种公共卫生措施也强调心臟衰竭的早期发现和治疗，进一步推动了对 CRT 的需求。这种慢性疾病的日益普及需要不断改进治疗解决方案，使 CRT 成为当代心臟衰竭管理策略不可或缺的一部分。

科技的快速进步

CRT 领域的技术创新和进步为全球市场的成长做出了重大贡献。主要参与者加大研发 (R&D) 力度，不断改进 CRT 设备，提升其功效、安全性和病患相容性。多点起搏和自适应演算法等创新正在实现更个人化和高效的治疗，满足心臟衰竭患者的多样化需求。先进技术的整合也有助于与其他医疗系统和患者监测工具的无缝协调。技术的不断发展将 CRT 的益处扩展到更广泛的患者群体，同时确保该疗法始终处于心臟衰竭治疗的前沿。

有利的政府和监管支持

政府和监管支援在塑造 CRT 市场方面发挥着至关重要的作用。透过提供明确的监管途径，政府正在促进新的和改进的 CRT 设备更快地获得批准。许多国家也投资于研究计划，并与产业参与者合作，以促进该领域的创新。此外，政府支持的卫生计划和政策的重点是减轻心臟衰竭的负担，因此支持 CRT 等治疗方法。监管机构与加强心臟衰竭护理目标的这种一致表明了一种坚定的方法，这有助于促进成长、标准化实践和确保 CRT 在各个医疗保健系统中的可及性。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球心臟再同步治疗 (CRT) 市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按类型

  • CRT-去颤器
    • 市场趋势
    • 市场预测
  • CRT心律调节器
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：按应用

  • 心室内不同步
    • 市场趋势
    • 市场预测
  • 室间 (VV) 不同步
    • 市场趋势
    • 市场预测
  • 房室 (AV) 不同步
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：依最终用户

  • 医院
    • 市场趋势
    • 市场预测
  • 心臟中心
    • 市场趋势
    • 市场预测
  • 门诊手术中心
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Biotronik SE & Co. KG
    • Boston Scientific Corporation
    • LivaNova Plc
    • Medico SpA
    • Medtronic Plc
    • Merit Medical Systems Inc.
    • MicroPort Scientific Corporation
Product Code: SR112024A2787

The global cardiac resynchronization therapy (CRT) market size reached US$ 5.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.3 Billion by 2032, exhibiting a growth rate (CAGR) of 5.4% during 2024-2032. The rising prevalence of heart failure, increase in government and regulatory support, favorable reimbursement policies, and expansion of healthcare infrastructure in emerging economies are some of the major factors propelling the market.

Cardiac resynchronization therapy (CRT) is an advanced medical procedure used to treat heart failure symptoms in certain patients. This treatment involves the use of a specialized device that is surgically implanted in the chest, known as a CRT device, which is akin to a pacemaker. The device functions by transmitting electrical impulses to the chambers of the heart, thereby coordinating their contractions. This synchronization can enhance the heart's efficiency, alleviating symptoms such as fatigue and shortness of breath that often accompany heart failure. CRT is typically considered for individuals with moderate to severe heart failure who display evidence of electrical disarray within the heart, in conjunction with optimal medical therapy. The implementation of CRT signifies a targeted approach to heart failure management, aimed at improving the quality of life and overall functional capacity of patients.

Rapid healthcare infrastructure development, particularly in emerging economies, is playing a vital role in expanding the reach of CRT devices, which will stimulate market growth during the forecast period. As nations invest in modernizing medical facilities, training healthcare professionals, and strengthening healthcare systems, access to specialized treatments like CRT is becoming more widespread. This, coupled with a rise in medical tourism, where patients seek treatment in countries offering advanced healthcare technologies at competitive costs, is fueling the market growth. Furthermore, the increasing public-private partnerships are fostering collaborations between governments and private entities to finance and promote CRT. Enhanced patient awareness through educational campaigns and professional workshops is also facilitating the understanding and acceptance of CRT, accelerating the product adoption rate. In addition, strategic collaborations between manufacturers for product development, marketing, and distribution are supporting market growth. Besides this, the emergence of local manufacturers offering cost-effective CRT solutions is fostering competition and making therapy more accessible, thus propelling the growth of the cardiac resynchronization therapy market.

Cardiac Resynchronization Therapy (CRT) Market Trends/Drivers:

Increase in Prevalence of Heart Failure

The rising incidence of heart failure globally is a key factor driving the growth of the cardiac resynchronization therapy (CRT) market. As heart failure becomes more prevalent, particularly in aging populations and areas with increased rates of obesity and diabetes, the demand for effective treatments like CRT is escalating. The ability of CRT to improve symptoms and overall quality of life in selected patients with heart failure underscores its importance. Various public health initiatives are also emphasizing early detection and treatment of heart failure, further propelling the need for CRT. The growing prevalence of this chronic condition necessitates continuous advancement in therapeutic solutions, making CRT an integral part of contemporary heart failure management strategies.

Rapid Technological Advancements

Technological innovation and advancements in the field of CRT are contributing significantly to the growth of the global market. Increased research and development (R&D) efforts by key players are continuously refining CRT devices, enhancing their efficacy, safety, and patient compatibility. Innovations like multi-point pacing and adaptive algorithms are enabling more personalized and efficient therapies, catering to the diverse needs of heart failure patients. The integration of sophisticated technologies also facilitates seamless coordination with other medical systems and patient monitoring tools. This constant evolution in technology is extending the benefits of CRT to a wider patient demographic while ensuring that the therapy remains at the forefront of heart failure treatment.

Favorable Government and Regulatory Support

Government and regulatory support play a crucial role in shaping the CRT market. By providing clear regulatory pathways, governments are facilitating faster approvals of new and improved CRT devices. Many countries are also investing in research initiatives and collaborating with industry players to foster innovation in the field. Moreover, government-backed health programs and policies are focusing on reducing the burden of heart failure and are thus endorsing treatments like CRT. This alignment of regulatory bodies with the objective of enhancing heart failure care demonstrates a committed approach, which is instrumental in fostering growth, standardizing practices, and ensuring the accessibility of CRT across various healthcare systems.

Cardiac Resynchronization Therapy (CRT) Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global cardiac resynchronization therapy (CRT) market report, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on type, application, and end user.

Breakup by Type:

CRT-Defibrillator

CRT-Pacemaker

CRT-Defibrillator represents the most popular type

The report has provided a detailed breakup and analysis of the market based on the type. This includes CRT-Defibrillator and CRT-Pacemaker. According to the report, CRT-Defibrillator represented the largest segment.

The CRT-Defibrillator (CRT-D) offers dual functionality in treating heart failure patients. Unlike standard CRT devices, CRT-D combines the features of cardiac resynchronization with defibrillation capabilities. This integrated approach enables the device to synchronize the heart's chambers, improving its efficiency, as well as to detect and correct life-threatening arrhythmias. By delivering a shock to the heart when it detects irregular rhythms, the CRT-D acts as a safeguard, adding an extra layer of protection for patients at high risk of sudden cardiac arrest. The all-encompassing nature of CRT-D extends its applicability, offering a comprehensive solution for managing both the chronic symptoms of heart failure and acute, critical arrhythmias. Additionally, improvements in device miniaturization, battery life, and programmability have contributed to its popularity. This consolidation of functions into one device, providing multifaceted care, has made CRT-D a preferred option, thus fueling the segment growth.

Breakup by Application:

Intraventricular Dyssynchrony

Interventricular (V-V) Dyssynchrony

Atrioventricular (A-V) Dyssynchrony

Intraventricular Dyssynchrony dominates the market

The report has provided a detailed breakup and analysis of the market based on the application. This includes intraventricular dyssynchrony, interventricular (V-V) dyssynchrony, and atrioventricular (A-V) dyssynchrony. According to the report, intraventricular dyssynchrony represented the largest segment.

Intraventricular dyssynchrony refers to the uncoordinated contraction of the heart's ventricles, leading to inefficient pumping and worsening heart failure symptoms. This specific form of dyssynchrony has been identified in a significant number of heart failure patients, making it a primary target for CRT. The use of CRT in managing intraventricular dyssynchrony is well-established, offering marked improvements in both symptoms and overall cardiac function. The precise targeting and correction of this dyssynchrony through CRT enables the heart to pump more efficiently, enhancing the patient's quality of life and reducing hospitalization rates. Research studies and clinical trials have further supported the effectiveness of CRT in this application, solidifying its position as a standard treatment. The pervasive presence of intraventricular dyssynchrony among heart failure patients and the proven success of CRT in addressing this condition are fueling the segment growth.

Breakup by End User:

Hospitals

Cardiac Centers

Ambulatory Surgery Centers

Others

Hospitals hold the largest share in the market

A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes hospitals, cardiac centers, ambulatory surgery centers, and others. According to the report, hospitals accounted for the largest market share.

Hospitals are often the primary setting for the diagnosis and treatment of heart failure, including the implantation and management of CRT devices. The complexity of CRT requires specialized equipment, skilled healthcare professionals, and coordinated post-procedure care, resources that hospitals are typically well-equipped to provide. Additionally, larger hospitals often have dedicated cardiac units with experts trained specifically in CRT, enabling comprehensive patient care from initial consultation through post-surgical monitoring. Many hospitals also engage in research and collaborate with device manufacturers, further aligning themselves with the advancements in CRT. The emphasis on integrated care pathways, coupled with the support of multi-disciplinary teams within the hospital setting, ensures that patients receive a seamless experience. This combination of resources, expertise, and patient-centric care is supporting the growth of the hospital segment.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share since the region boasts a sophisticated healthcare infrastructure, emphasis on medical innovation, and robust regulatory support that have fostered a favorable environment for the adoption and advancement of CRT. North America is also home to a significant number of leading medical research institutions and device manufacturers, promoting continuous innovation in CRT technology. In addition, high awareness levels among healthcare professionals and the general population about heart failure and its treatment options contribute to the growing acceptance of CRT. Moreover, the prevalence of lifestyle-related diseases leading to heart failure is relatively high in this region, creating a substantial patient base. Favorable reimbursement policies and insurance coverage further ease the accessibility of CRT for patients. These factors, along with the increasing focus on patient-centered care, position North America as the largest regional market for cardiac resynchronization therapy (CRT).

Competitive Landscape:

The market is experiencing steady growth as key players are actively engaged in research and development (R&D), striving to innovate and enhance CRT technology. Collaborating with healthcare institutions, they are focused on creating devices with improved efficiency, patient compatibility, and integration with other healthcare systems. Expansion into emerging markets and strategic alliances with local distributors are also part of their growth strategies. Through acquisitions and partnerships, these industry leaders are consolidating their presence, sharing expertise, and fostering technological advancements. Investments in clinical trials to validate new applications and continued engagement with regulatory bodies for compliance ensure alignment with global healthcare needs. We also expect the market to witness new entrants, consolidation of portfolios, and a rise in strategic collaborations to drive healthy competition within the CRT domain.

The market research report has provided a comprehensive analysis of the competitive landscape in the global cardiac resynchronization therapy (CRT) market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories

Biotronik SE & Co. KG

Boston Scientific Corporation

LivaNova Plc

Medico S.p.A.

Medtronic Plc

Merit Medical Systems Inc.

MicroPort Scientific Corporation

Recent Developments:

In July 2023, Biotronik SE & Co. KG announced the approval of its next-generation portfolio of Amvia Edge pacemakers and cardiac resynchronization therapy (CRT) devices by the U.S. Food and Drug Administration (FDA).

Abbott Laboratories has made recent developments in cardiac resynchronization therapy (CRT) by releasing updates to its implantable pacemakers and defibrillators, showcasing its commitment to continuously improve patient care.

Key Questions Answered in This Report:

  • How has the global cardiac resynchronization therapy (CRT) market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global cardiac resynchronization therapy (CRT) market?
  • What is the impact of each driver, restraint, and opportunity on the global cardiac resynchronization therapy (CRT) market?
  • What are the key regional markets?
  • Which countries represent the most attractive cardiac resynchronization therapy (CRT) market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the cardiac resynchronization therapy (CRT) market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the cardiac resynchronization therapy (CRT) market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the cardiac resynchronization therapy (CRT) market?
  • What is the competitive structure of the global cardiac resynchronization therapy (CRT) market?
  • Who are the key players/companies in the global cardiac resynchronization therapy (CRT) market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cardiac Resynchronization Therapy (CRT) Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 CRT-Defibrillator
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 CRT-Pacemaker
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Intraventricular Dyssynchrony
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Interventricular (V-V) Dyssynchrony
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Atrioventricular (A-V) Dyssynchrony
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cardiac Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Ambulatory Surgery Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Biotronik SE & Co. KG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Boston Scientific Corporation
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 LivaNova Plc
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Medico S.p.A.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 Medtronic Plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Merit Medical Systems Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 MicroPort Scientific Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio

List of Figures

  • Figure 1: Global: Cardiac Resynchronization Therapy Market: Major Drivers and Challenges
  • Figure 2: Global: Cardiac Resynchronization Therapy Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Cardiac Resynchronization Therapy Market: Breakup by Type (in %), 2023
  • Figure 4: Global: Cardiac Resynchronization Therapy Market: Breakup by Application (in %), 2023
  • Figure 5: Global: Cardiac Resynchronization Therapy Market: Breakup by End User (in %), 2023
  • Figure 6: Global: Cardiac Resynchronization Therapy Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 8: Global: Cardiac Resynchronization Therapy (CRT-Defibrillator) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Cardiac Resynchronization Therapy (CRT-Defibrillator) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Cardiac Resynchronization Therapy (CRT-Pacemaker) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Cardiac Resynchronization Therapy (CRT-Pacemaker) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Cardiac Resynchronization Therapy (Intraventricular Dyssynchrony) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Cardiac Resynchronization Therapy (Intraventricular Dyssynchrony) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Cardiac Resynchronization Therapy (Interventricular (V-V) Dyssynchrony) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Cardiac Resynchronization Therapy (Interventricular (V-V) Dyssynchrony) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Cardiac Resynchronization Therapy (Atrioventricular (A-V) Dyssynchrony) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Cardiac Resynchronization Therapy (Atrioventricular (A-V) Dyssynchrony) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Cardiac Resynchronization Therapy (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Cardiac Resynchronization Therapy (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Cardiac Resynchronization Therapy (Cardiac Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Cardiac Resynchronization Therapy (Cardiac Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Cardiac Resynchronization Therapy (Ambulatory Surgery Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Cardiac Resynchronization Therapy (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Cardiac Resynchronization Therapy (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Cardiac Resynchronization Therapy (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: North America: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: North America: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: United States: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: United States: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Canada: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Canada: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Asia Pacific: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Asia Pacific: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: China: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: China: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Japan: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Japan: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: India: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: India: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: South Korea: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: South Korea: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Australia: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Australia: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Indonesia: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Indonesia: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Others: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Others: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Europe: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Europe: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Germany: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Germany: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: France: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: France: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: United Kingdom: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: United Kingdom: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Italy: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Italy: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Spain: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Spain: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Russia: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Russia: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Others: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Others: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Latin America: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Latin America: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Brazil: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Brazil: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Mexico: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Mexico: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Others: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Others: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Middle East and Africa: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Middle East and Africa: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Global: Cardiac Resynchronization Therapy (CRT) Industry: SWOT Analysis
  • Figure 75: Global: Cardiac Resynchronization Therapy (CRT) Industry: Value Chain Analysis
  • Figure 76: Global: Cardiac Resynchronization Therapy (CRT) Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cardiac Resynchronization Therapy Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Cardiac Resynchronization Therapy Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Cardiac Resynchronization Therapy Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Cardiac Resynchronization Therapy Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Cardiac Resynchronization Therapy Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Cardiac Resynchronization Therapy Market Structure
  • Table 7: Global: Cardiac Resynchronization Therapy Market: Key Players